NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 47 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $226,000 | +11.3% | 171,364 | +68.9% | 0.00% | 0.0% |
| Q3 2019 | $203,000 | -33.7% | 101,462 | -19.1% | 0.00% | 0.0% |
| Q1 2019 | $306,000 | +264.3% | 125,475 | +116.8% | 0.00% | – |
| Q4 2018 | $84,000 | -74.7% | 57,869 | -53.0% | 0.00% | -100.0% |
| Q3 2018 | $332,000 | – | 123,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|